Simulations Plus
Lancaster · Founded 1996
About Simulations Plus
Simulations Plus is a developer of Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) and Physiologically-Based Pharmacokinetic (PBPK) modeling and simulation software for the pharmaceutical and biotechnology, generics, chemical, cosmetic, and food ingredient industries today. Our software allows pharmaceutical scientists to predict certain key potential endpoints and dynamics, in silico, thereby reducing research & development costs and helping clients make better projects decisions... sooner. Founded in 1996, Simulations Plus employs over 60 employees and is publicly-traded on the NASDAQ stock exchange (ticker symbol = SLP).Our headquarters are based in Lancaster, California, with our pharmacometrics consulting team located in Buffalo, New York. Trusted distributors handle sales and scientific support in Asian territories. 19 of the top 20 pharmaceutical companies, plus numerous mid- and small-sized companies and all major regulatory agencies, license our modeling & simulation technology.
Company Facts
- Founded: 1996
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $1.7M
- Funding stage: IPO
- Last round: Grant (Nov 2024)
- Ticker: nasdaq:SLP
- Website: http://www.simulations-plus.com
- Phone: +1 (661)723-7723
Industries & Categories
Biotechnology, Computer, Data Mining, Enterprise Software, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/simulations-plus-55486 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.